Dopamine transporter single-photon emission computed tomography (DAT-SPECT) allows us to evaluate the integrity of the nigrostriatal pathway in vivo, providing the promise of an objective and quantitative biomarker of neuronal degeneration in PD [14]. This evidence concerns the gene SLC6A3 and Parkinson disease.